
|Articles|August 26, 2016
Biosimilar Naming Convention Debate Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top news of the week from Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/biosimilar-naming-convention-debate-highlights-spe" target="_blank">View the story "Biosimilar Naming Convention Debate Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updates in Treatment of Unresectable Hepatocellular Carcinoma
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
Notable Updates in Medication Therapy Management in 2025
4
Pharmacy Leaders Highlight Innovations in Acute and Ambulatory Care Medication-Use
5












































































































































































































